An official website of the United States government
Home
Name
Berubicin
Alternate Names
None
Abbreviations
None
Category
Chemotherapy
Subcategory
topoisomerase II inhibitor
NSC Number
None
Primary Site
Brain
Histology
Glioma
Remarks
June 12, 2020: Berubicin was granted Orphan Drug Designation by FDA for the treatment of malignant gliomas.
Coding
This drug should be coded
